David Shine and Steven Epstein's representation of Merck in the divestiture of Sirna Therapeutics was reported by The Deal Pipeline, Law360 and <em>Mergers & Acquisitions</em>

David Shine and Steven Epstein's representation of Merck in the divestiture of Sirna Therapeutics was reported by The Deal Pipeline, Law360 and Mergers & Acquisitions

Corporate partners David Shine and Steven Epstein's representation of Merck in its divestiture of Sirna Therapeutics to Alnylam Pharmaceuticals, an RNAi therapeutics company, was reported by The Deal Pipeline, Law360 and Mergers & Acquisitions.

Additional Information
news-detail.inc